The new report by Expert Market Research titled, ‘Global Exocrine Pancreatic Insufficiency Treatment Market Report and Forecast 2021-2026’, gives an in-depth analysis of the global exocrine pancreatic insufficiency treatment market, assessing the market based on its segments like disease management, diagnosis, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analyzing the market based on the SWOT and Porter’s Five Forces models.

Request a free sample copy in PDF or view the report summary@

The key highlights of the report include:

Market Overview (2016-2026)

  • Historical Market Size (2020): USD 3.6 Billion
  • Forecast CAGR (2021-2026): 8.27%
  • Forecast Market Size (2026): USD 5.8 Billion

The growth in the market is being driven by the rising demand for effectual treatments against exocrine pancreatic insufficiency caused by increasing prevalence of chronic pancreatic and cystic fibrosis amongst the geriatric populations, infants, and young adults. Furthermore, owing to the sedentary lifestyles and unhealthy eating habits, the spur in the global cases of diabetes has become a leading cause of exocrine pancreatic insufficiency, thereby invigorating the market for EPI treatments.

Industry Definition and Segmentation

Exocrine Pancreatic Insufficiency (EPI) refers to a medical condition characterized by the inability to properly digest food due to insufficient levels of digestive enzymes produced by pancreas. The disease is most commonly detected by clinical tests such as blood, stool, malabsorption, and pancreatic function tests.

Explore the full report with the table of contents@

On the basis of disease management, the market can be divided into:

  • Nutritional Management
  • Pancreatic Enzyme Replacement Therapy (PERT)
  • Lifestyle Modifications approach

Based on diagnosis, the market can be segmented into:

The regional markets for the product include:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Market Trends

The market is anticipated to be driven by the rising focus on pharmaceutical research and development (R&D) for an effective treatment method is significantly contributing to the overall growth of the market. In order to address the increasing demand for the treatment of exocrine pancreatic insufficiency, key industry players, in conjunction with governing agencies, are significantly contributing towards the development of a cure, and hence pushing the growth of the market. Moreover, pancreatic enzyme replacement therapy (PERT) to aid in the digestion and for the absorption of fats is anticipated to hold a substantial share in the overall growth of the market owing to its status as a conventional therapy.

Latest News on Exocrine Pancreatic Insufficiency Treatment Market@

Key Market Players

The major players in the market are AbbVie Inc., Janssen Global Services, LLC, Chiesi Farmaceutici S.p.A., Nordmark Arzneimittel GmbH and Co. KG, Digestive Care, Inc, Cilian AG, Anthera Pharmaceuticals, Inc., Allergan plc., First Wave BioPharma, Inc. (AzurRx), and Aptalis Pharma Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally.

At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.

Media Contact

Company Name: EMR Inc.
Contact Person: Billy batson, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
City: Sheridan
State: Wyoming
Country: United States

Read More Reports:-

Global Sustained Release Coatings Market:

Switzerland Biosensors Market:

Global Surgical Instrument Tracking Systems Market:

Global Speciality Biocides Market:

Global Stock Video Market:

Introducing Procurement Resources Services of EMR Inc.

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.